Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study

類似資料

• Half-Dose Verteporfin Combined with Half-Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
  著者:: Liu, Chun-Fu, 等
  出版事項: (2014)
• Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis)
  著者:: Lai, Timothy Y. Y., 等
  出版事項: (2015)
• Half dose verteporfin PDT for central serous chorioretinopathy
  著者:: Stewart, J M
  出版事項: (2006)
• Macular sensitivity after half-dose verteporfin photodynamic therapy in central serous chorioretinopathy
  著者:: Sanguansak, Thuss, 等
  出版事項: (2015)
• Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report
  著者:: Lai Timothy YY, 等
  出版事項: (2011-05-01)